Your browser doesn't support javascript.
loading
PD-1 blockade in combination with dasatinib potentiates induction of anti-acute lymphocytic leukemia immunity.
Koller, Paul; Baran, Natalia; Harutyunyan, Karine; Cavazos, Antonio; Mallampati, Saradhi; Chin, Renee L; Jiang, Zhou; Sun, Xian; Lee, Heng-Huan; Hsu, Jennifer L; Williams, Patrick; Huang, Xuelin; Curran, Michael A; Hung, Mien-Chie; Konopleva, Marina.
Affiliation
  • Koller P; Hematology, City of Hope Comprehensive Cancer Center, Duarte, California, USA.
  • Baran N; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Harutyunyan K; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Cavazos A; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Mallampati S; Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Chin RL; Cancer Systems Imaging, The University of Texas Health Science Center at Houston, Houston, Texas, USA.
  • Jiang Z; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Sun X; Department of Medical Oncology, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, Guangdong, China.
  • Lee HH; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Hsu JL; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Williams P; Genentech Inc, South San Francisco, California, USA.
  • Huang X; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Curran MA; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Hung MC; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Konopleva M; Graduate Institute of Biomedical Sciences, Research Center for Cancer Biology, and Center for Molecular Medicine, China Medical University, Taichung, Taiwan.
J Immunother Cancer ; 11(10)2023 10.
Article in En | MEDLINE | ID: mdl-37793852
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Precursor Cell Lymphoblastic Leukemia-Lymphoma / Programmed Cell Death 1 Receptor Limits: Animals / Humans Language: En Journal: J Immunother Cancer Year: 2023 Type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Precursor Cell Lymphoblastic Leukemia-Lymphoma / Programmed Cell Death 1 Receptor Limits: Animals / Humans Language: En Journal: J Immunother Cancer Year: 2023 Type: Article Affiliation country: United States